Literature DB >> 19308316

Lazy, dynamic or minimally recrudescent? On the elusive nature and location of the mycobacterium responsible for latent tuberculosis.

S Ehlers1.   

Abstract

In the absence of symptoms characteristic of tuberculosis (TB), a condition termed clinical latency, diagnosis is currently impossible by detection of the microorganism itself and resorts to the demonstration of an immunological memory response to antigens of Mycobacterium tuberculosis (Mtb). Whether latency is synonymous to chronic persistent infection with viable Mtb in all instances has been difficult to establish. The physical and physiological state of Mtb during latency is much disputed: are organisms mostly dormant, in a nonreplicating state of persistence, and characterized by lipid inclusions and metabolic adaptation to hypoxia, or do they continue to replicate and sometimes even escape from the fringes of granulomatous lesions or alveolar epithelial cells into adjacent airways, thereby inducing recurring immune responses? The physical nature of Mtb during latency is important as it determines which antimicrobial agents may be used to kill it, which immunomodulating strategies (including post-exposure vaccines) may be appropriate to contain it, and which diagnostic measures may be most useful to discriminate latent from reactivating infection. Two major viewpoints exist: one argues that Mtb persists mostly in a lazy state within granulomatous lesions, but periodically recrudesces, and that there is considerable heterogeneity for different sites within the lesion and within the infected lung. Throughout latency, there is a dynamic immunological interplay between Mtb and the host, necessitating continuous recruitment of cells into the granuloma, and reactivation occurs when this dynamic cellular exchange becomes dysregulated. Another view holds that dormant Mtb reside within alveolar epithelial cells in the lung apices and in adipocytes, with reactivation being associated with the upregulation of resuscitation promoting factors within Mtb and the escape of newly dividing microorganisms into alveoli and bronchi in the form of lipid pneumonia. These views need not be mutually exclusive. However, if minimal intermittent recrudescence were to take place within the alveolar space, this would contradict the very definition of latency, which implies that no access of Mtb to the airways exists during latency.

Entities:  

Mesh:

Year:  2009        PMID: 19308316     DOI: 10.1007/s15010-009-8450-7

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  80 in total

Review 1.  New insights into the function of granulomas in human tuberculosis.

Authors:  Timo Ulrichs; Stefan H E Kaufmann
Journal:  J Pathol       Date:  2006-01       Impact factor: 7.996

2.  Ipr1 gene mediates innate immunity to tuberculosis.

Authors:  Hui Pan; Bo-Shiun Yan; Mauricio Rojas; Yuriy V Shebzukhov; Hongwei Zhou; Lester Kobzik; Darren E Higgins; Mark J Daly; Barry R Bloom; Igor Kramnik
Journal:  Nature       Date:  2005-04-07       Impact factor: 49.962

Review 3.  How can immunology contribute to the control of tuberculosis?

Authors:  S H Kaufmann
Journal:  Nat Rev Immunol       Date:  2001-10       Impact factor: 53.106

Review 4.  Cellular hypersensitivity and cellular immunity in the pathogensis of tuberculosis: specificity, systemic and local nature, and associated macrophage enzymes.

Authors:  A M Dannenberg
Journal:  Bacteriol Rev       Date:  1968-06

5.  Identification of nitric oxide synthase as a protective locus against tuberculosis.

Authors:  J D MacMicking; R J North; R LaCourse; J S Mudgett; S K Shah; C F Nathan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

Review 6.  A philosophy of anti-infectives as a guide in the search for new drugs for tuberculosis.

Authors:  Carl Nathan; Ben Gold; Gang Lin; Melanie Stegman; Luiz Pedro Sorio de Carvalho; Omar Vandal; Aditya Venugopal; Ruslana Bryk
Journal:  Tuberculosis (Edinb)       Date:  2008-08       Impact factor: 3.131

7.  Mycobacterium tuberculosis gene expression during adaptation to stationary phase and low-oxygen dormancy.

Authors:  M I Voskuil; K C Visconti; G K Schoolnik
Journal:  Tuberculosis (Edinb)       Date:  2004       Impact factor: 3.131

8.  Location of persisting mycobacteria in a Guinea pig model of tuberculosis revealed by r207910.

Authors:  Anne J Lenaerts; Donald Hoff; Sahar Aly; Stefan Ehlers; Koen Andries; Luis Cantarero; Ian M Orme; Randall J Basaraba
Journal:  Antimicrob Agents Chemother       Date:  2007-05-21       Impact factor: 5.191

9.  Recognition of stage-specific mycobacterial antigens differentiates between acute and latent infections with Mycobacterium tuberculosis.

Authors:  Abebech Demissie; Eliane M S Leyten; Markos Abebe; Liya Wassie; Abraham Aseffa; Getahun Abate; Helen Fletcher; Patrick Owiafe; Philip C Hill; Roger Brookes; Graham Rook; Alimuddin Zumla; Sandra M Arend; Michel Klein; Tom H M Ottenhoff; Peter Andersen; T Mark Doherty
Journal:  Clin Vaccine Immunol       Date:  2006-02

10.  Characterization of in vitro chlamydial cultures in low-oxygen atmospheres.

Authors:  Nicolai Juul; Helene Jensen; Malene Hvid; Gunna Christiansen; Svend Birkelund
Journal:  J Bacteriol       Date:  2007-07-13       Impact factor: 3.490

View more
  31 in total

1.  Tuberculosis: an old but still fascinating disease.

Authors: 
Journal:  Infection       Date:  2009-04       Impact factor: 3.553

Review 2.  Latent tuberculosis: what the host "sees"?

Authors:  Hannah P Gideon; JoAnne L Flynn
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

3.  Evaluation of a mouse model of necrotic granuloma formation using C3HeB/FeJ mice for testing of drugs against Mycobacterium tuberculosis.

Authors:  Emily R Driver; Gavin J Ryan; Donald R Hoff; Scott M Irwin; Randall J Basaraba; Igor Kramnik; Anne J Lenaerts
Journal:  Antimicrob Agents Chemother       Date:  2012-04-02       Impact factor: 5.191

4.  Mycobacterium tuberculosis promotes HIV trans-infection and suppresses major histocompatibility complex class II antigen processing by dendritic cells.

Authors:  Morgan A Reuter; Nicole D Pecora; Clifford V Harding; David H Canaday; David McDonald
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

5.  Detection of Mycobacterium tuberculosis in latently infected lungs by immunohistochemistry and confocal microscopy.

Authors:  Selvakumar Subbian; Eliseo Eugenin; Gilla Kaplan
Journal:  J Med Microbiol       Date:  2014-08-26       Impact factor: 2.472

Review 6.  The impact of mucosal infections on acquisition and progression of tuberculosis.

Authors:  S Perry; R Hussain; J Parsonnet
Journal:  Mucosal Immunol       Date:  2011-03-16       Impact factor: 7.313

7.  CCL5 participates in early protection against Mycobacterium tuberculosis.

Authors:  Bridget Vesosky; Erin K Rottinghaus; Paul Stromberg; Joanne Turner; Gillian Beamer
Journal:  J Leukoc Biol       Date:  2010-04-06       Impact factor: 4.962

8.  Mycobacterium tuberculosis ftsZ expression and minimal promoter activity.

Authors:  Manjot Kiran; Erin Maloney; Hava Lofton; Ashwini Chauhan; Rasmus Jensen; Renata Dziedzic; Murty Madiraju; Malini Rajagopalan
Journal:  Tuberculosis (Edinb)       Date:  2009-12       Impact factor: 3.131

9.  Spontaneous latency in a rabbit model of pulmonary tuberculosis.

Authors:  Selvakumar Subbian; Liana Tsenova; Paul O'Brien; Guibin Yang; Nicole L Kushner; Sven Parsons; Blas Peixoto; Dorothy Fallows; Gilla Kaplan
Journal:  Am J Pathol       Date:  2012-09-05       Impact factor: 4.307

Review 10.  Use of siRNA molecular beacons to detect and attenuate mycobacterial infection in macrophages.

Authors:  Remo George; Renata Cavalcante; Celso Carvalho; Elyana Marques; Jonathan B Waugh; M Tino Unlap
Journal:  World J Exp Med       Date:  2015-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.